| Company Name: | Thermo Fisher Scientific Inc | | Ticker Symbol: | TMO | | | WWW Address: | www.thermofisher.com |
| CEO: | Mr. Marc N. Casper | | No. of Employees: | 38,900 |
| Common Issue Type: | CS | | Business Description: | Thermo Fisher Scientific Inc., offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs.
|
| | | Industry Information: | HEALTH SERVICES - Medical Laboratories & Research [more like this] |
| | Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 86.28 |  -1.07 | - | - | 87.41 | 88.08 | 85.79 | 2421921 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 30,967.7 | 358.9 | 0.82 | 3.43 | 0.54 | 22.9 | 0.7 | 88.08 - 48.14 |
| | KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 86.28 | $ | | PE Ratio - LTM | 22.9 | |
| Market Capitalisation | 30,967.7 | mil |
| Latest Shares Outstanding | 358.9 | mil |
| Earnings pS (EPS) | 3.43 | $ |
| Dividend pS (DPS) | 0.54 | ¢ |
| Dividend Yield | 0.7 | % |
| Dividend Payout Ratio | 16 | % |
| Revenue per Employee | 321,591 | $ |
| Effective Tax Rate | 0.9 | % |
| Float | 285.2 | mil |
| Float as % of Shares Outstanding | 79.5 | % |
| Foreign Sales | 6,086 | mil |
| Domestic Sales | 6,424 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 26.60 | % |
| Research & Devlopment (R&D) as % of Revenue | 3.00 | % |
| Gross Profit Margin | 50.1 | % |
| EBITDA Margin | 20.5 | % |
| Pre-Tax Profit Margin | 10.3 | % |
| Assets Turnover | 0.5 | % |
| Return on Assets (ROA) | 4.5 | % |
| Return on Equity (ROE) | 7.9 | % |
| Return on Capital Invested (ROCI) | 5.5 | % |
| Current Ratio | 2.2 | |
| Leverage Ratio (Assets/Equity) | 1.8 | |
| Interest Cover | 6.2 | |
| Total Debt/Equity (Gearing Ratio) | 0.46 | |
| LT Debt/Total Capital | 30.0 | % |
| Working Capital pS | 7.89 | $ |
| Cash pS | 2.80 | $ |
| Book-Value pS | 43.46 | $ |
| Tangible Book-Value pS | -12.27 | $ |
| Cash Flow pS | 6.21 | $ |
| Free Cash Flow pS | 0.98 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.99 | |
| Price/Tangible Book Ratio | -7.03 | |
| Price/Cash Flow | 13.9 | |
| Price/Free Cash Flow | 88.2 | |
| P/E as % of Industry Group | 109.0 | % |
| P/E as % of Sector Segment | 87.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Dividend Declared Date | 02/25/2013 |
| Dividend Ex-Date | 03/12/2013 |
| Dividend Record Date | 03/14/2013 |
| Dividend Pay Date | 04/14/2013 |
| Dividend Amount | 150 |
| Type of Payment | Cash Payment |
| Dividend Rate | 0.60 |
| Current Dividend Yield | 0.7 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 16.0 |
| 5-Y Average Payout Ratio | 3.0 |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | | | | | PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.0 | 101 | 19,607 | 60,561 |
| 4 Weeks | 88.08 | 80.21 | 81.13 | 6.3 | 102 | 19,380 | 348,836 |
| 13 Weeks | 88.08 | 71.60 | 72.95 | 18.3 | 108 | 25,686 | 1,592,562 |
| 26 Weeks | 88.08 | 61.38 | 62.64 | 37.7 | 117 | 22,665 | 2,787,747 |
| 52 Weeks | 88.08 | 48.14 | 51.68 | 67.0 | 133 | 21,203 | 5,237,024 |
| YTD | 88.08 | 64.54 | - | 35.3 | 117 | 23,331 | 2,286,439 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 86.44 | 85.52 | 80.58 | 72.21 | 68.09 | 0.82 | 0.93 |
| | | | GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 4.54 | 86.4 | 5.85 |
| Income | 11.20 | 83.6 | 14.69 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 38.67 | NA | 41.18 |
| R&D | 10.16 | NA | 13.84 |
| Normalized Inc. | 10.62 | NA | 14.03 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 2.9 | 2.9 | 6.7 |
| Earnings % | 21.2 | 21.2 | -11.4 |
| EPS % | 25.3 | 25.3 | 29.4 |
| EPS $ | 0.19 | 0.19 | 0.78 |
| | | | SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 9.99 |
| Current Ratio | 2.3 |
| Quick Ratio (Acid Test) | 1.3 |
| Liquidity Ratio (Cash) | 0.41 |
| Receivables Turnover | 6.9 |
| Average Collection Period | 52 |
| Working Capital/Equity | 17.7 |
| Working Capital pS | 7.67 |
| Cash-Flow pS | 6.05 |
| Free Cash-Flow pS | 1.40 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 2.42 |
| Financial Leverage Ratio (Assets/Equity) | 1.8 |
| Debt Ratio | 43.7 |
| Total Debt/Equity (Gearing Ratio) | 0.46 |
| LT Debt/Equity | 0.45 |
| LT Debt/Capital Invested | 43.9 |
| LT Debt/Total Liabilities | 58.7 |
| Interest Cover | 6.3 |
| Interest/Capital Invested | 0.95 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 26.54 |
| Tobin's Q Ratio | 1.13 |
| Current P/E Ratio - LTM | 22.90 |
| Enterprise Value (EV)/EBITDA | 16.52 |
| Enterprise Value (EV)/Free Cash Flow | 85.45 |
| Dividend Yield | 0.7 |
| Price/Tangible Book Ratio - LTM | -7.03 |
| Price/Book Ratio - LTM | 1.99 |
| Price/Cash Flow Ratio | 13.9 |
| Price/Free Cash Flow Ratio - LTM | 88.2 |
| Price/Sales Ratio | 2.45 |
| P/E Ratio (1 month ago) - LTM | 21.2 |
| P/E Ratio (26 weeks ago) - LTM | 20.2 |
| P/E Ratio (52 weeks ago) - LTM | 18.7 |
| 5-Y High P/E Ratio | 27.7 |
| 5-Y Low P/E Ratio | 11.7 |
| 5-Y Average P/E Ratio | 19.2 |
| Current P/E Ratio as % of 5-Y Average P/E | 119 |
| P/E as % of Industry Group | 109.0 |
| P/E as % of Sector Segment | 87.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 22.4 |
| PER SHARE FIGURES |
| LT Debt pS | 19.67 |
| Current Liabilities pS | 5.86 |
| Tangible Book Value pS - LTM | -12.27 |
| Book Value pS - LTM | 43.46 |
| Capital Invested pS | 62.68 |
| Cash pS - LTM | 2.80 |
| Cash Flow pS - LTM | 6.21 |
| Free Cash Flow pS - LTM | 0.98 |
| Earnings pS (EPS) | 3.43 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 3.99 |
| Free Cash Flow Margin 5YEAR AVG | -1.85 |
| Net Profit Margin | 9.4 |
| Net Profit Margin - 5YEAR AVRG. | 9.7 |
| Equity Productivity | 0.81 |
| Return on Equity (ROE) | 7.6 |
| Return on Equity (ROE) - 5YEAR AVRG. | 7.1 |
| Capital Invested Productivity | 0.56 |
| Return on Capital Invested (ROCI) | 5.2 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 5.7 |
| Assets Productivity | 0.50 |
| Return on Assets (ROA) | 4.3 |
| Return on Assets (ROA) - 5YEAR AVRG. | 4.6 |
| Gross Profit Margin | 50.1 |
| Gross Profit Margin - 5YEAR AVRG. | 48.5 |
| EBITDA Margin - LTM | 20.5 |
| EBIT Margin - LTM | 12.3 |
| Pre-Tax Profit Margin | 10.1 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 10.1 |
| Effective Tax Rate | 0.9 |
| Effective Tax Rate - 5YEAR AVRG. | 8.8 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 133 |
| Revenue per Employee | 321,591 |
| Net Income per Employee | 30,280 |
| Average Collection Period | 52 |
| Receivables Turnover | 6.9 |
| Day's Inventory Turnover Ratio | 81 |
| Inventory Turnover | 4.5 |
| Inventory/Sales | 11.5 |
| Accounts Payble/Sales | 5.13 |
| Assets/Revenue | 2.00 |
| Net Working Capital Turnover | 4.56 |
| Fixed Assets Turnover | 0.55 |
| Total Assets Turnover | 0.5 |
| Revenue per $ Cash | 14.70 |
| Revenue per $ Plant | 7.25 |
| Revenue per $ Common Equity | 0.81 |
| Revenue per $ Capital Invested | 0.56 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 26.8 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 26.4 |
| Research & Devlopment (R&D) as % of Revenue | 3.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 3.0 |
|
|  
| | |  |  | |
| |
